Mikrobiom und neurodegenerative Erkrankungen

Christiane Frahm1, Otto W. Witte1
1Universitätsklinikum Jena, Jena, Deutschland

Tóm tắt

Từ khóa


Tài liệu tham khảo

Bauerl C, Collado MC, Diaz Cuevas A et al (2018) Shifts in gut microbiota composition in an APP/PSS1 transgenic mouse model of Alzheimer’s disease during lifespan. Lett Appl Microbiol 66:464–471

Berer K, Mues M, Koutrolos M et al (2011) Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 479:538–541

Calvo-Barreiro L, Eixarch H, Montalban X et al (2018) Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosis. Autoimmun Rev 17:165–174

Cani PD, Bibiloni R, Knauf C et al (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57:1470–1481

Cattaneo A, Cattane N, Galluzzi S et al (2017) Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging 49:60–68

Erny D, Hrabe de Angelis AL, Jaitin D et al (2015) Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci 18:965–977

Forsyth CB, Shannon KM, Kordower JH et al (2011) Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson’s disease. PLoS ONE 6:e28032

Haghikia A, Jorg S, Duscha A et al (2015) Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine. Immunity 43:817–829

Harach T, Marungruang N, Duthilleul N et al (2017) Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota. Sci Rep 7:41802

Hufnagel DA, Tukel C, Chapman MR (2013) Disease to dirt: The biology of microbial amyloids. PLoS Pathog 9:e1003740

Keshavarzian A, Green SJ, Engen PA et al (2015) Colonic bacterial composition in Parkinson’s disease. Mov Disord 30:1351–1360

Minter MR, Zhang C, Leone V et al (2016) Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer’s disease. Sci Rep 6:30028

Postuma RB, Gagnon JF, Pelletier A et al (2013) Prodromal autonomic symptoms and signs in Parkinson’s disease and dementia with Lewy bodies. Mov Disord 28:597–604

Rao SSC, Rehman A, Yu S et al (2018) Brain fogginess, gas and bloating: A link between SIBO, probiotics and metabolic acidosis. Clin Transl Gastroenterol 9:162

Sampson TR, Debelius JW, Thron T et al (2016) Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease. Cell 167:1469–1480.e12

Sender R, Fuchs S, Milo R (2016) Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans. Cell 164:337–340

Shahi SK, Freedman SN, Mangalam AK (2017) Gut microbiome in multiple sclerosis: The players involved and the roles they play. Gut Microbes 8:607–615

Shen L, Liu L, Ji HF (2017) Alzheimer’s disease histological and behavioral manifestations in transgenic mice correlate with specific gut microbiome state. J Alzheimers Dis 56:385–390

Socias SB, Gonzalez-Lizarraga F, Avila CL et al (2018) Exploiting the therapeutic potential of ready-to-use drugs: Repurposing antibiotics against amyloid aggregation in neurodegenerative diseases. Prog Neurobiol 162:17–36

Stanley D, Mason LJ, Mackin KE et al (2016) Translocation and dissemination of commensal bacteria in post-stroke infection. Nat Med 22:1277–1284

Tankou SK, Regev K, Healy BC et al (2018) A probiotic modulates the microbiome and immunity in multiple sclerosis. Ann Neurol 83:1147–1161

Tomas-Camardiel M, Rite I, Herrera AJ et al (2004) Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood-brain barrier, and damage in the nigral dopaminergic system. Neurobiol Dis 16:190–201

Ulusoy A, Phillips RJ, Helwig M et al (2017) Brain-to-stomach transfer of alpha-synuclein via vagal preganglionic projections. Acta Neuropathol 133:381–393

Villumsen M, Aznar S, Pakkenberg B et al (2019) Inflammatory bowel disease increases the risk of Parkinson’s disease: A Danish nationwide cohort study 1977–2014. Gut 68:18–24

Wen SW, Wong CHY (2017) An unexplored brain-gut microbiota axis in stroke. Gut Microbes 8:601–606

Wilson QN, Wells M, Davis AT et al (2018) Greater microbial translocation and vulnerability to metabolic disease in healthy aged female monkeys. Sci Rep 8:11373

Xu R, Wang Q (2016) Towards understanding brain-gut-microbiome connections in Alzheimer’s disease. BMC Syst Biol 10(Suppl 3):63

Yin J, Liao SX, He Y et al (2015) Dysbiosis of gut microbiota with reduced trimethylamine-N-oxide level in patients with large-artery atherosclerotic stroke or transient Ischemic attack. J Am Heart Assoc. https://doi.org/10.1161/JAHA.115.002699

Zaura E, Brandt BW, Teixeira de Mattos MJ et al (2015) Same exposure but two radically different responses to antibiotics: Resilience of the salivary microbiome versus long-term microbial shifts in feces. mBio. https://doi.org/10.1128/mBio.01693-15

Zhuang ZQ, Shen LL, Li WW et al (2018) Gut microbiota is altered in patients with alzheimer’s disease. J Alzheimers Dis 63:1337–1346